NCT00657852 - Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Bone Disease, Metabolic

Interventions

DRUG

Disodium pamidronate

Single dose of 90 mg disodium pamidronate within days 7-12 and at 3 months after liver transplantation, diluted in 500 ml of 5% glucose serum and administered as a 4-hour continuous intravenous infusion

DRUG

Placebo

500 ml of 5% glucoside serum infusions within days 7-12 and at 3 months after liver transplantation and administered as a 4-hour continuous intravenous infusion

Trial Locations (1)

08036

Hospital Clinic i Provincial of Barcelona, Barcelona